Follow the Corindus Vascular Robotics, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 4 January 2016 (J). Among the most active insiders: Bachrach Hillel. The full history is accessible without an account.
Analysts rate Corindus Vascular Robotics, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Corindus Vascular Robotics, Inc. is a company focused on developing robotic technologies for cardiovascular procedures. It aims to enhance the precision and safety of surgical interventions.